951884-73-4 Usage
Uses
Used in Organic Chemistry:
2-(3-Bromophenyl)-1-(pyrrolidin-1-yl)ethanone is used as a reagent in various synthetic reactions, contributing to the formation of complex organic molecules.
Used in Pharmaceutical Synthesis:
2-(3-Bromophenyl)-1-(pyrrolidin-1-yl)ethanone serves as a building block in the synthesis of pharmaceuticals, playing a crucial role in creating biologically active compounds for medicinal applications.
Used in Production of Diverse Organic Molecules:
Due to its unique structure and functional groups, 2-(3-Bromophenyl)-1-(pyrrolidin-1-yl)ethanone is an important intermediate in the production of a wide range of organic molecules, enhancing the capabilities of organic synthesis.
It is important to handle 2-(3-Bromophenyl)-1-(pyrrolidin-1-yl)ethanone with care due to its potential reactivity and toxicological properties, ensuring safety in its applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 951884-73-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,1,8,8 and 4 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 951884-73:
(8*9)+(7*5)+(6*1)+(5*8)+(4*8)+(3*4)+(2*7)+(1*3)=214
214 % 10 = 4
So 951884-73-4 is a valid CAS Registry Number.
951884-73-4Relevant academic research and scientific papers
Ambient Decarboxylative Arylation of Malonate Half-Esters via Oxidative Catalysis
Moon, Patrick J.,Yin, Shengkang,Lundgren, Rylan J.
supporting information, p. 13826 - 13829 (2016/11/06)
We report decarboxylative carbonyl α-arylation by coupling of arylboron nucleophiles with malonic acid derivatives. This process is enabled by the merger of aerobic oxidative Cu catalysis with decarboxylative enolate interception reminiscent of malonyl-CoA reactivity in polyketide biosynthesis. This method enables the synthesis of monoaryl acetate derivatives containing electrophilic functional groups that are incompatible with existing α-arylation reactivity paradigms. The utility of the reaction is demonstrated in drug intermediate synthesis and late-stage functionalization.
FUSED PYRAZINE DERIVATIVES AS KINASE INHIBITORS
-
Page/Page column 35, (2010/06/11)
A series of quinoxaline derivatives, and analogues thereof, which are functionalised further by a substituted phenyl or pyridinyl moiety, being selective inhibitors of PO kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.
